Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Teriflunomide for multiple sclerosis.
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
Defining the clinical course of multiple sclerosis: The 2013 revisions.
Episode 47 with Dr. Hans Lassmann on oxidative stress in MS
Nature Medicine Retracts MS Paper With Ghost Data by Former GSK Researcher
Episode 36 with Dr. Jenny Ting on the inflammasome
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
American Academy of Neurology Fall Conference 2014
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
The Role of the Gut Microbiome on Multiple Sclerosis Risk and Progression
Glatiramer promotes oligodendroglial cell maturation in a cuprizone-induced demyelination model.
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Episode 43 with Dr. May Han on following patients through the course of their disease
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.
Primary progressive multiple sclerosis-why we are failing.
Demyelination and Remyelination: From Mechanism to Therapy
The Oxford English Corpus: Facts about the language, The Story of Dictionaries
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Risk alleles for multiple sclerosis identified by a genomewide study.
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.

Pages